Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

67 та иш

Иш: Molecular dynamics insights into the redox effects on PD-1/PD-L1 and PD-1/PD-L2 interactions

  1. Definition and testing of the GROMOS force-field versions 54A7 and 54B7

    Nathan Schmid, Andreas P. Eichenberger, Alexandra Choutko +4

    Мақола20113 иқтибос
    ABI
  2. The evolution of cancer surgery and future perspectives

    Lynda Wyld, Riccardo A. Audisio, Graeme J. Poston

    Шарҳ мақола20143 иқтибос
    ABI
  3. PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

    Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener +4

    Шарҳ мақола20163 иқтибос
    ABI
  4. Immune Checkpoint Inhibitors in Cancer Therapy

    Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani +6

    Шарҳ мақола20223 иқтибос
    ABI
  5. PD-1/PD-L1 pathway: current researches in cancer.

    Yanyan Han, Dandan Liu, Lianhong Li

    Мақола20203 иқтибос
    ABI
  6. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

    Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo +1

    Шарҳ мақола20173 иқтибос
    ABI
  7. Non-thermal plasma-induced immunogenic cell death in cancer

    Marian Khalili, Lynsey Daniels, Abraham Lin +5

    Мақола20192 иқтибос
    ABI
  8. Generation and propagation of radical reactions on proteins

    Clare L. Hawkins, Michael J. Davies

    Шарҳ мақола20012 иқтибос
    ABI
  9. The Protein Data Bank

    Helen M. Berman, Tammy Battistuz, Talapady N. Bhat +16

    Мақола20022 иқтибос
    ABI
  10. PD-1 and Its Ligands in Tolerance and Immunity

    Mary Keir, Manish J. Butte, Gordon J. Freeman +1

    Шарҳ мақола20082 иқтибос
    ABI
  11. PD-1/PD-L1 in Disease

    Nyanbol Kuol, Lily Stojanovska, Kulmira Nurgali +1

    Мақола20172 иқтибос
    ABI
  12. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics

    Xiao Han, Hongjun Li, Daojia Zhou +2

    Мақола20202 иқтибос
    ABI
  13. Transmembrane domain–driven PD-1 dimers mediate T cell inhibition

    Elliot A. Philips, Jia Liu, Audun Kvalvaag +16

    Мақола20242 иқтибос
    ABI
  14. Glycosylation and Its Role in Immune Checkpoint Proteins: From Molecular Mechanisms to Clinical Implications

    Jingyi Liu, Ximo Xu, Hao Zhong +5

    Шарҳ мақола20242 иқтибос
    ABI
  15. Proteomic Investigation of Immune Checkpoints and Some of Their Inhibitors

    Marco Agostini, Pietro Traldi, Mahmoud Hamdan

    Шарҳ мақола20242 иқтибос
    ABI